These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 12140003

  • 1. Effects of long-term Donepezil therapy on rCBF of Alzheimer's patients.
    Nobili F, Vitali P, Canfora M, Girtler N, De Leo C, Mariani G, Pupi A, Rodriguez G.
    Clin Neurophysiol; 2002 Aug; 113(8):1241-8. PubMed ID: 12140003
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
    Nobili F, Koulibaly M, Vitali P, Migneco O, Mariani G, Ebmeier K, Pupi A, Robert PH, Rodriguez G, Darcourt J.
    J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621
    [Abstract] [Full Text] [Related]

  • 4. SPECT follow-up study of cerebral blood flow changes during Donepezil therapy in patients with Alzheimer's disease.
    Shimizu S, Hanyu H, Iwamoto T, Koizumi K, Abe K.
    J Neuroimaging; 2006 Jan; 16(1):16-23. PubMed ID: 16483272
    [Abstract] [Full Text] [Related]

  • 5. Predicting the neural effect of switching from donepezil to galantamine based on single-photon emission computed tomography findings in patients with Alzheimer's disease.
    Oka M, Nakaaki S, Negi A, Miyata J, Nakagawa A, Hirono N, Mimura M.
    Psychogeriatrics; 2016 Mar; 16(2):121-34. PubMed ID: 26114924
    [Abstract] [Full Text] [Related]

  • 6. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease.
    Nakano S, Asada T, Matsuda H, Uno M, Takasaki M.
    J Nucl Med; 2001 Oct; 42(10):1441-5. PubMed ID: 11585854
    [Abstract] [Full Text] [Related]

  • 7. Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease.
    Ceravolo R, Volterrani D, Tognoni G, Dell'Agnello G, Manca G, Kiferle L, Rossi C, Logi C, Strauss HW, Mariani G, Murri L.
    Clin Neuropharmacol; 2004 Oct; 27(4):166-70. PubMed ID: 15319702
    [Abstract] [Full Text] [Related]

  • 8. Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period.
    López-Pousa S, Turon-Estrada A, Garre-Olmo J, Pericot-Nierga I, Lozano-Gallego M, Vilalta-Franch M, Hernández-Ferràndiz M, Morante-Muñoz V, Isern-Vila A, Gelada-Batlle E, Majó-Llopart J.
    Dement Geriatr Cogn Disord; 2005 Oct; 19(4):189-95. PubMed ID: 15677866
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the regional cerebral blood flow changes during long-term donepezil therapy in patients with Alzheimer's disease using 3DSRT.
    Kimura N, Kumamoto T, Masuda T, Hanaoka T, Okazaki T, Arakawa R.
    J Neuroimaging; 2012 Jul; 22(3):299-304. PubMed ID: 21699607
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of a high dosage of donepezil for Alzheimer's disease as examined by single-photon emission computed tomography imaging.
    Kanaya K, Abe S, Sakai M, Fujii H, Koizumi K, Iwamoto T.
    Psychogeriatrics; 2012 Sep; 12(3):172-8. PubMed ID: 22994615
    [Abstract] [Full Text] [Related]

  • 11. Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease.
    Tanaka M, Namiki C, Thuy DH, Yoshida H, Kawasaki K, Hashikawa K, Fukuyama H, Kita T.
    J Neurol Sci; 2004 Oct 15; 225(1-2):135-41. PubMed ID: 15465097
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of linearization correction on statistical parametric mapping (SPM): a 99mTc-HMPAO brain perfusion SPECT study in mild Alzheimer's disease.
    Ansar MA, Osaki Y, Kazui H, Oku N, Takasawa M, Kimura Y, Begum NN, Ikejiri Y, Takeda M, Hatazawa J.
    Ann Nucl Med; 2006 Oct 15; 20(8):511-7. PubMed ID: 17134017
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Changes in the rCBF images of patients with Alzheimer's disease receiving Donepezil therapy.
    Staff RT, Gemmell HG, Shanks MF, Murray AD, Venneri A.
    Nucl Med Commun; 2000 Jan 15; 21(1):37-41. PubMed ID: 10717900
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Quantitative analysis of the effects of donepezil on regional cerebral blood flow in Alzheimer's disease by using an automated program, 3DSRT.
    Tateno M, Kobayashi S, Utsumi K, Morii H, Fujii K.
    Neuroradiology; 2008 Aug 15; 50(8):723-7. PubMed ID: 18483726
    [Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.
    J Am Geriatr Soc; 2001 Dec 15; 49(12):1590-9. PubMed ID: 11843990
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of treatment with donepezil hydrochloride and changes in regional cerebral blood flow in patients with Alzheimer's disease.
    Yoshida T, Ha-Kawa S, Yoshimura M, Nobuhara K, Kinoshita T, Sawada S.
    Ann Nucl Med; 2007 Jul 15; 21(5):257-65. PubMed ID: 17634843
    [Abstract] [Full Text] [Related]

  • 20. The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: a longitudinal SPECT study.
    Hanyu H, Sato T, Hirao K, Kanetaka H, Iwamoto T, Koizumi K.
    J Neurol Sci; 2010 Mar 15; 290(1-2):96-101. PubMed ID: 19931870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.